Verano Holdings (VRNO) Receivables - Net (2021 - 2026)
Verano Holdings (VRNO) reported Receivables - Net of $32.1 million for Q1 2026, down 19.68% year-over-year from $40.0 million in Q1 2025, and up 3.91% quarter-over-quarter from $30.9 million in Q4 2025.
Verano Holdings (VRNO) Receivables - Net (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Receivables - Net data on file, last reported at $32.1 million in Q1 2026.
- Receivables - Net for Q1 2026 came in at $32.1 million, down 19.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.1 million (down 19.68% YoY), and the FY2025 annual result was $30.9 million, down 23.18% from the prior year.
- Receivables - Net advanced to $32.1 million in Q1 2026 per VRNO's latest filing, from $30.9 million in the prior quarter.
- Over five years, Receivables - Net peaked at $46.9 million in Q3 2024 and troughed at $13.3 million in Q2 2022.
- A 5-year average of $31.5 million and a median of $32.3 million in 2025 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2025: Receivables - Net soared 135.11% in 2023, then slumped 30.85% in 2025.
- A 5-year view of Receivables - Net shows it stood at $16.6 million in 2022, then soared by 135.11% to $39.0 million in 2023, then increased by 3.29% to $40.3 million in 2024, then slipped by 23.18% to $30.9 million in 2025, then gained by 3.91% to $32.1 million in 2026.
- Business Quant data shows VRNO's Receivables - Net at $32.1 million in Q1 2026, $30.9 million in Q4 2025, and $32.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.14 Mn |
| Mar 31, 2026 | 32.14 Mn |
| Dec 31, 2025 | 30.93 Mn |
| Dec 31, 2025 | 30.93 Mn |
| Sep 30, 2025 | 32.46 Mn |
| Sep 30, 2025 | 32.46 Mn |
| Jun 30, 2025 | 30.76 Mn |
| Jun 30, 2025 | 30.76 Mn |
| Mar 31, 2025 | 40.02 Mn |
| Mar 31, 2025 | 40.02 Mn |
| Dec 31, 2024 | 40.26 Mn |
| Dec 31, 2024 | 40.26 Mn |
| Sep 30, 2024 | 46.94 Mn |
| Sep 30, 2024 | 46.94 Mn |
| Jun 30, 2024 | 43.21 Mn |
| Jun 30, 2024 | 43.21 Mn |
| Mar 31, 2024 | 41.93 Mn |
| Mar 31, 2024 | 41.93 Mn |
| Dec 31, 2023 | 38.98 Mn |
| Dec 31, 2023 | 38.98 Mn |